The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

'Functional unblinding was a major barrier to the approval of psychedelics as medicines to treat the patients who need them most,' said Dr. Andrew Chadeayne, CaaMTech CEO. 'I'm incredibly proud that ...

Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effectMarks ...

Thursday, Adial Pharmaceuticals Inc (NASDAQ:ADIL) said it has completed a pharmacokinetics (PK) study of AD04 for Alcohol Use ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...

On July 31, 2024, Adial announced that, after an extensive review of data and information from the Onward Study, it had filed a new patent application to protect core assets and extend IP exclusivity ...

US-based biopharmaceutical company Radella Pharmaceuticals has reported topline outcomes from a Phase Ia trial that assessed ...

Radella Pharmaceuticals, LLC., a clinical-stage biopharmaceutical company developing innovative therapies for cardiometabolic disorders, today announced topline results from the Phase 1a MD-18 ...

The intricate interplay between redox signaling and inflammation lies at the core of numerous pathologies, ranging from chronic inflammatory disorders to acute tissue damage. This call for papers ...

In a recent article, researchers introduced a novel photoacoustic imaging technique, SRCPT, enabling precise tracking of drug ...

Breakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein ...

Pharmaceutical spectroscopy techniques like NMR, mass spectrometry, and UV-Vis play essential roles in pharmacokinetics, supporting each stage of drug development from discovery and preclinical ...